The American Society of Radiation Oncology, or ASTRO, has selected Jeffrey Wong, M.D., as a fellow in its organization.
Wong, chair of City of Hope’s Department of Radiation Oncology, will receive the award at a special ceremony at ASTRO’s annual meeting in Chicago in early November. He was one of 12 radiation oncologists nationwide selected for the honor.
|Jeffrey Wong (Photo by Kaminsky Productions)|
Members of ASTRO are eligible to become fellows if they have been part of the society for at least 20 years, have served in a leadership role for the organization and have made a significant contribution to the field of radiation oncology.
“Dr. Wong is a leader in creating and improving applications for radiation therapy, and his leadership has been instrumental in the national and international prominence of City of Hope’s radiation oncology program,” said Alexandra Levine, M.D., chief medical officer. “It is only fitting that he be recognized by his peers for excellence.”
The four primary pathways to becoming a fellow are excellence in research, patient care, education, and leadership and service. While Wong has served ASTRO by contributing to committees and leading panels and symposia, he was selected primarily for his work in research and patient care.
“I am honored to be selected as a fellow in ASTRO,” Wong said. “As the largest radiation oncology society in the world, it serves as our international forum for the exchange of ideas and is critical for defining future therapy strategies, technologies and the direction of the field.”
Wong noted that deep involvement in ASTRO is central to the direction and growth of research and patient care for City of Hope’s Department of Radiation Oncology; it is also vital to the refinement of practice guidelines, which ultimately improve patient care.
A member of City of Hope’s medical staff since 1985, Wong is recognized as an expert in the use of targeted radiation therapy using radiolabeled antibodies for colorectal, breast and lung cancer. He is known for his efforts in targeted therapy and targeted total marrow irradiation using image-guided intensity-modulated radiation therapy as well.
Wong’s clinical interests include prostate, colorectal, lung and breast cancer. He also is associate director of the Prostate Cancer Program.